Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Previous Page

The content of this section has been developed in collaboration between COR2ED GmbH (an Independent Medical Education Company) and the experts serving as Scientific Directors on this programme:

  • Dr Elena Castro (Spanish National Cancer Research Center, Madrid, Spain),
  • Dr Alexander Wyatt (University of British Columbia, Vancouver, Canada),
  • Prof. Gerhardt Attard (University College London, United Kingdom)
  • Prof. Steven Joniau (University Hospitals Leuven, Belgium)

Medical writing support was provided by Daniel Salamon, PhD and Tracey Gashi, PhD, of COR2ED GmbH. Subsequently the content was donated to the European Society for Medical Oncology (ESMO).

ESMO, COR2ED GmbH and the Scientific Directors wish to thank AstraZeneca for their support with an independent sponsorship grant. Within the context of this independent sponsorship grant AstraZeneca had no influence over the content

ESMO only accepts content from third parties after careful evaluation of its educational and scientific relevance to the ESMO target audience. Eligible material should meet the essential criterion of non-promotional intent. Such material may be published in other resources, but the content donor has given permission to ESMO for use in OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings